Cargando…

Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy

Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents due to their excellent biocompatibility, biodegradability, and structural versatility. The principal application of polymeric nanoparticles in medicine is for cancer therapy, with increased tumor accumulation, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Di, Ma, Yuanyuan, Xu, Xiaoxuan, Xie, Jinbing, Ju, Shenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267819/
https://www.ncbi.nlm.nih.gov/pubmed/34249894
http://dx.doi.org/10.3389/fbioe.2021.707319
_version_ 1783720227119300608
author Chang, Di
Ma, Yuanyuan
Xu, Xiaoxuan
Xie, Jinbing
Ju, Shenghong
author_facet Chang, Di
Ma, Yuanyuan
Xu, Xiaoxuan
Xie, Jinbing
Ju, Shenghong
author_sort Chang, Di
collection PubMed
description Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents due to their excellent biocompatibility, biodegradability, and structural versatility. The principal application of polymeric nanoparticles in medicine is for cancer therapy, with increased tumor accumulation, precision delivery of anticancer drugs to target sites, higher solubility of pharmaceutical properties and lower systemic toxicity. Recently, the stimuli-responsive polymeric nanoplatforms attracted more and more attention because they can change their physicochemical properties responding to the stimuli conditions, such as low pH, enzyme, redox agents, hypoxia, light, temperature, magnetic field, ultrasound, and so on. Moreover, the unique properties of stimuli-responsive polymeric nanocarriers in target tissues may significantly improve the bioactivity of delivered agents for cancer treatment. This review introduces stimuli-responsive polymeric nanoparticles and their applications in tumor theranostics with the loading of chemical drugs, nucleic drugs and imaging molecules. In addition, we discuss the strategy for designing multifunctional polymeric nanocarriers and provide the perspective for the clinical applications of these stimuli-responsive polymeric nanoplatforms.
format Online
Article
Text
id pubmed-8267819
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82678192021-07-10 Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy Chang, Di Ma, Yuanyuan Xu, Xiaoxuan Xie, Jinbing Ju, Shenghong Front Bioeng Biotechnol Bioengineering and Biotechnology Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents due to their excellent biocompatibility, biodegradability, and structural versatility. The principal application of polymeric nanoparticles in medicine is for cancer therapy, with increased tumor accumulation, precision delivery of anticancer drugs to target sites, higher solubility of pharmaceutical properties and lower systemic toxicity. Recently, the stimuli-responsive polymeric nanoplatforms attracted more and more attention because they can change their physicochemical properties responding to the stimuli conditions, such as low pH, enzyme, redox agents, hypoxia, light, temperature, magnetic field, ultrasound, and so on. Moreover, the unique properties of stimuli-responsive polymeric nanocarriers in target tissues may significantly improve the bioactivity of delivered agents for cancer treatment. This review introduces stimuli-responsive polymeric nanoparticles and their applications in tumor theranostics with the loading of chemical drugs, nucleic drugs and imaging molecules. In addition, we discuss the strategy for designing multifunctional polymeric nanocarriers and provide the perspective for the clinical applications of these stimuli-responsive polymeric nanoplatforms. Frontiers Media S.A. 2021-06-25 /pmc/articles/PMC8267819/ /pubmed/34249894 http://dx.doi.org/10.3389/fbioe.2021.707319 Text en Copyright © 2021 Chang, Ma, Xu, Xie and Ju. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Chang, Di
Ma, Yuanyuan
Xu, Xiaoxuan
Xie, Jinbing
Ju, Shenghong
Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title_full Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title_fullStr Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title_full_unstemmed Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title_short Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
title_sort stimuli-responsive polymeric nanoplatforms for cancer therapy
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267819/
https://www.ncbi.nlm.nih.gov/pubmed/34249894
http://dx.doi.org/10.3389/fbioe.2021.707319
work_keys_str_mv AT changdi stimuliresponsivepolymericnanoplatformsforcancertherapy
AT mayuanyuan stimuliresponsivepolymericnanoplatformsforcancertherapy
AT xuxiaoxuan stimuliresponsivepolymericnanoplatformsforcancertherapy
AT xiejinbing stimuliresponsivepolymericnanoplatformsforcancertherapy
AT jushenghong stimuliresponsivepolymericnanoplatformsforcancertherapy